Find Funding Opportunities

pThe purpose of this notice is to inform applicants of the early expiration of a href="https://grants.nih.gov/grants/guide/pa-files/PAR-24-204.html"PAR-24-204/a - Summer Research Education Experience Program (R25 Clinical Trial Not Allowed). The remaining Summer R25 receipt date of March 17, 2027 is canceled and Participating ICs will no longer accept applications under this NOFO./ppActive Summer R25 awards are not affected by this Notice and are anticipated to continue until the end of their project period, as scheduled. Summer R25 applications submitted for the March 17, 2026 receipt date will undergo peer review and will be considered for funding in accordance with Participating IC priorities and the availability of funds./p

pThe purpose of this time-sensitive Request for Information (RFI) is to solicit input from people living with Parkinsons and Parkinsonisms, families, caregivers, advocates, scientists, clinicians, and the broader community to identify the most important gaps and opportunities in research, care and services. The scope of this RFI includes Parkinson's disease and all other neurodegenerative Parkinsonisms, such as multiple system atrophy, corticobasal degeneration, progressive supranuclear palsy, and Parkinsons-related dementia. This input will be used to develop the National Plan to End Parkinsons./p

pThe purpose of this notice is to inform applicants of the early expiration of a href="https://grants.nih.gov/grants/guide/pa-files/PAR-25-234.html"PAR-25-234/a- NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed).The last receipt date for a href="https://www.grants.nih.gov/grants/guide/pa-files/PAR-25-234.html"PAR-25-234/a will be thestrong June 9, 2026 receipt date/strong. The remaining NINDS F32 receipt dates scheduled after June 9, 2026, are canceled, and NINDS will not accept applications under this NOFO beyond that date./ppActive NINDS F32 awardsare not affected by this Notice and are anticipated to continue until the end of their project period, as scheduled. NINDS F32 applications submitted for the June9, 2026 receipt date will still undergo peer review and will be considered for funding in accordance with NINDS priorities and the availability of funds."/p

pThe purpose of this Notice is to inform potential applicants that the National Institute of Neurological Disorders and Stroke (a href="https://www.ninds.nih.gov/"NINDS/a) is participating, effective for the February/March 2026 receipt dates, in the following Mentored Research Scientist Development Award (Parent K01) Notices of Funding Opportunity:/pulli/li/ul

pNotice of publication of a ROA/p

pNotice of publication of a ROA/p

p style="margin-left:0px;"The purpose of this notice is to rescind a href="https://grants.nih.gov/grants/guide/notice-files/NOT-NS-24-079.html"NOT-NS-24-079/a "NINDS' Policy on Special Council Review of Research Applications," effective immediately./pp style="margin-left:0px;"Applicants should refer to a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-049.html"NOT-OD-26-019/a for NIH's Policy on Letters of Intent and Unsolicited Applications Requesting $500,000 or More in Direct Costs./p

pThe purpose of this Notice is to inform potential applicants of NINDS's participation in a href="https://grants.nih.gov/grants/guide/pa-files/PA-25-304.html"PA-25-304/a: NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed), effective for the June 16, 2026, due date and subsequent due dates./ppThe following changes and updates (shown inistrong bold italics/strong/i) are made to a href="https://grants.nih.gov/grants/guide/pa-files/PA-25-304.html"PA-25-304/a to reflect NINDS's participation in this notice of funding opportunity announcement (NOFO)./ppstrongAssistance Listing Number(s)/strong: 93.865, 93.173, 93.867, 93.879, 93.121, 93.286, 93.273, 93.855, 93.242, 93.172, 93.279, 93.361, 93.866, 93.113, 93.143, 93.213, 93.310, 93.307, 93.846, istrong93.853/strong/i, 93.393, 93.394, 93.395, 93.396, 93.399/p

pThe purpose of this notice is to inform the extramural community that effective May 08, 2026, NINDS will expire a href="https://grants.nih.gov/grants/guide/pa-files/PA-25-150.html"PA-25-150: Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Not Allowed)/a.brbr/p

pThe purpose of this notice is to inform the extramural community that, effective immediately, the following NOFO is expired:/ppa href="https://grants.nih.gov/grants/guide/pa-files/PAR-25-326.html"PAR-25-326/a: Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)/pp/ppApplicants interested in applying to the Ultra-rare Gene-based Therapy (URGenT) programare encouraged to continue applying to the following NOFO:/ppa href="https://grants.nih.gov/grants/guide/pa-files/PAR-25-327.html"PAR-25-327/a: Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)/pp/p